IndraLab

Statements

USP22 activates Neoplasm Invasiveness. 2 / 2
| 2
reach
"We report that deletion of USP22 in pancreatic tumor cells reduced the infiltration of myeloid cells and promoted the infiltration of T cells and NK cells, leading to an improved response to combination immunotherapy."
31871120
reach
"Ablation of USP22 in liver tumor cells has been shown to increase tumor immunogenicity and promote infiltration of T cells into the resulting liver tumors."
31871120